Other
1 Parent Features
| Id | Name | Short Name | Type |
|---|---|---|---|
| IPR002231 | 5-hydroxytryptamine receptor family | 5HT_rcpt | Family |
| Name | 5-Hydroxytryptamine 1A receptor | Short Name | 5HT1A_rcpt |
| Type | Family | Description | 5-hydroxytryptamine (5-HT) or serotonin, is a neurotransmitter that it is primarily found in the gastrointestinal (GI) tract, platelets, and in the central nervous system (CNS). It is implicated in a vast array of physiological and pathophysiological pathways. Receptors for 5-HT mediate both excitatory and inhibitory neurotransmission, and modulate the release of many neurotransmitters including glutamate, GABA, dopamine, epinephrine/norepinephrine, and acetylcholine, as well as many hormones, including oxytocin, prolactin, vasopressin and cortisol. In the CNS, 5-HT receptors can influence various neurological processes, such as aggression, anxiety and appetite and, as a, result are the target of a variety of pharmaceutical drugs, including many antidepressants, antipsychotics and anorectics []. The 5-HT receptors are grouped into a number of distinct subtypes, classified according to their antagonist susceptibilities and their affinities for 5-HT. With the exception of the 5-HT3 receptor, which is a ligand-gated ion channel [], all 5-HT receptors are members of the rhodopsin-like G protein-coupled receptor family [], and they activate an intracellular second messenger cascade to produce their responses. The 5-HT1 receptors are a subfamily of 5-HT receptors that were originally classified according to their inhibition of adenylyl cyclase, degree of sequence similarity and their overlapping pharmacological specificities. The subfamily is comprised of five different receptors 5-HT1A, 5-HT1B, 5-HT1D, 5-HT1E, 5-HT1F, and they can couple to Gi/Go and mediate inhibitory neurotransmission, although signalling via other transduction systems are known. One of the 5-HT1 receptors, the 5-HT1E receptor, is yet to achieve receptor status from the International Union of Basic and Clinical Pharmacology (IUPHAR), since a robust response mediated via the protein has not been reported in the literature.5-HT1A receptors are the most widespread of all the 5-HT receptors. They are found pre- and post-synaptically [, , , ]: in the raphe nuclei they are somatodendritic and act as autoreceptors to inhibit cell firing; whereas postsynaptic 5-HT1A receptors are present in a number of limbic structures, particularly the hippocampus [, , ]. 5-HT1A receptors are involved in many neuromodulative processes, and are potential anxiolytic and hypertensive targets [, , , ]. Receptor antagonists like buspirone []and flesinoxan []have been shown to relieve anxiety [, ]and depression [, ]. Other 5-HT1A receptor agonists decrease blood pressure and heart rate via a central mechanism, by inducing peripheral vasodilation []. This also increases heat dissipation from the organism, causing a decrease in body temperature [, ]. 5-HT1A receptors have been implicated in the neuroendocrine regulation of adrenocorticotrophic hormone (ACTH) []. In the CNS, 5-HT1A receptors exist in the cerebral cortex, hippocampus, septum, amygdala, and in the raphe nucleus in high densities, whilst lower amounts also exist in the basal ganglia and thalamus [, ]. |
|
Feedback
Feedback
|
| Id | Name | Short Name | Type |
|---|---|---|---|
| IPR002231 | 5-hydroxytryptamine receptor family | 5HT_rcpt | Family |
To cite PlanMine, please refer to the following publication:Rozanski, A., Moon, H., Brandl, H., Martín-Durán, J. M., Grohme, M., Hüttner, K., Bartscherer, K., Henry, I., & Rink, J. C. |
| This database is part of a project that received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement number 649024). |
Powered by
